檢索結果 - Sebastian Stintzing
- Showing 1 - 20 results of 42
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials 由 Clemens Gießen, Ruediger P. Laubender, Donna P. Ankerst, Sebastian Stintzing, Dominik Paul Modest, Ulrich Mansmann, Volker Heinemann
出版 2012Revisão -
14
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AI... 由 Dominik Paul Modest, Ruediger P. Laubender, Sebastian Stintzing, Clemens Gießen, Christoph Schulz, Michael Haas, Ulrich Mansmann, Volker Heinemann
出版 2012Artigo -
15
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type me... 由 Volker Heinemann, Fernando Rivera, Bert H. O’Neil, Sebastian Stintzing, Reija Koukakis, Jan-Henrik Terwey, Jean‐Yves Douillard
出版 2016Revisão -
16
-
17
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer 由 Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, Josep Tabernero, Eric Van Cutsem, Frank Beier, Regina Esser, Heinz‐Josef Lenz, Volker Heinemann
出版 2016Artigo -
18
-
19
Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial 由 Clemens Gießen, Ruediger P. Laubender, Ludwig Fischer von Weikersthal, Andreas Schalhorn, Dominik Paul Modest, Sebastian Stintzing, Michael Haas, Ulrich Mansmann, Volker Heinemann
出版 2013Artigo -
20
Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal tran... 由 Sebastian Stintzing, Christine Kapaun, Rüdiger P. Laubender, Andreas Jung, Jens Neumann, Dominik Paul Modest, Clemens Gießen, Nicolas Moosmann, Andreas Wollenberg, Thomas Kirchner, Volker Heinemann
出版 2012Artigo
相關主題
Cancer
Internal medicine
Medicine
Colorectal cancer
Oncology
Cetuximab
Chemotherapy
Cancer research
Irinotecan
Bevacizumab
KRAS
Biology
Biochemistry
FOLFIRI
Immunotherapy
Oxaliplatin
Confidence interval
Epidermal growth factor receptor
Hazard ratio
Immunology
Randomized controlled trial
Surgery
Environmental health
Gene
Immune system
Population
Clinical endpoint
Chemistry
Clinical trial
Gastroenterology